Skip to main content

Advertisement

Log in

Update on the Diagnosis and Treatment of Achalasia

  • Review
  • Published:
Dysphagia Aims and scope Submit manuscript

Abstract

Achalasia is a rare disease of the esophagus with impaired relaxation of the lower esophageal sphincter and aperistalsis. The etiology is unknown but speculations include a viral or autoimmune etiology. All specialists dealing with swallowing and esophageal diseases should recognize the classic symptoms of dysphagia for solids/liquids, regurgitation, and choking, especially at night. High-resolution manometry is critical for the diagnosis with endoscopy and barium esophagram having a supportive role. The disease cannot be cured but most can return to near normal swallowing and a regular diet with appropriate therapy. Treatment includes smooth muscle relaxants, botulinum toxin injections to the lower sphincter, pneumatic dilation, Heller myotomy, and peroral endoscopic myotomy. One treatment does not fit all and a tailored approach through a multidiscipline team will give the best long-term outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Boeckxstaens GE, Zanitto G, Richter JE. Achaslasia. Lancet. 2014;383:89–93.

    Article  Google Scholar 

  2. Samo S, Carlsen DA, Gregory DL, et al. Incidence and prevalence of achalasia in central Chicago, 2004–2014, since widespread use of high resolution manometry. Clin Gastroenterol Hepatol. 2017;15:366–73.

    Article  PubMed  Google Scholar 

  3. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100(6):1404–14.

    Article  PubMed  Google Scholar 

  4. Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993;23(11):724–8.

    Article  CAS  PubMed  Google Scholar 

  5. Aggestrup S, Uddman R, Jensen SL, et al. Regulatory peptides in the lower esophageal sphincter of man. Regul Pept. 1985;10(2–3):167–78.

    Article  CAS  PubMed  Google Scholar 

  6. Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981;80(2):327–33.

    Article  CAS  PubMed  Google Scholar 

  7. de Oliveira RB, RezendeFilho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90(7):1119–24.

    PubMed  Google Scholar 

  8. Sodikoff JB, Lo AA, Shetuni BB, Kahrilas PJ, Yang GY, Pandolfino JE. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28(1):139–45.

    Article  CAS  PubMed  Google Scholar 

  9. Jones DB, Mayberry JF, Rhodes J, Munro J. Preliminary report of an association between measles virus and achalasia. J Clin Pathol. 1983;36(6):655–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Naik RD, Vaezi MF, Gerskon AA et al. Association of achalasia with active varicella zoster infection of the esophagus. Gastroenterol 2021

  11. Furuzawa-Carballeda J, Aguilar-Leon D, Gamboa-Dominguez A, et al. Achalasia–an autoimmune inflammatory disease: a cross-sectional study. J Immunol Res. 2015;2015:729217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr. Significant DQw1 association in achalasia. Dig Dis Sci. 1989;34(3):349–52.

    Article  CAS  PubMed  Google Scholar 

  13. De la Concha EG, Fernandez-Arquero M, Mendoza JL, et al. Contribution of HLA class II genes to susceptibility in achalasia. Tissue Antigens. 1998;52(4):381–4.

    Article  PubMed  Google Scholar 

  14. Verne GN, Hahn AB, Pineau BC, Hoffman BJ, Wojciechowski BW, Wu WC. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology. 1999;117(1):26–31.

    Article  CAS  PubMed  Google Scholar 

  15. Gockel I, Becker J, Wouters MM, et al. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet. 2014;46(8):901–4.

    Article  CAS  PubMed  Google Scholar 

  16. Booy JD, Takata J, Tomlinson G, Urbach DR. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus. 2012;25(3):209–13.

    Article  CAS  PubMed  Google Scholar 

  17. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002;47(1):15–9.

    Article  PubMed  Google Scholar 

  18. King D, Thomas T, Chandan JS, et al. Achalasia is associated with atopy in patients younger than 40 years of age. Am J Gastroenterol. 2021;116(2):416–9.

    Article  PubMed  Google Scholar 

  19. Eckardt AJ, Eckardt VF. Current clinical approach to achalasia. World J Gastroenterol. 2009;15(32):3969–75.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Richter JE. Achalasia: an update. J Neurogastroenterol Motil. 2010;16(3):232–42.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Eckardt V, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103:1732–8.

    Article  CAS  PubMed  Google Scholar 

  22. Urbach DR, Tomlinson G, Harnish JG. A measure of disease-specific health related quality of life for achalasia. Am J Gastroenterol. 2005;100:1668–76.

    Article  PubMed  Google Scholar 

  23. Slone S, Kumar A, Jacobs J, Velanovich V. Richter JE. Accuracy of achalasia quality of life and Eckardt scores for assessment of clinical improvement post treatment for achalasia. Dis Esophagus 2020 https://doi.org/10.1092/doaa080

  24. ASGE Standards and Practice Committee, Patria SF, Acosta R, et al. The role of endoscopy in the evaluation and management of achalasia. Gastrointestinal Endosc. 2014;79:191–201.

    Article  Google Scholar 

  25. Levine MS, Rubesin SE, Laufler IL. Barium studies in modern radiology. Do they have a role? Radiology. 2009;250:18–22.

    Article  PubMed  Google Scholar 

  26. Howard PJ, Maker G, Pryde A, et al. Five year prospective study of the incidence, clinical features and diagnosis of achalasia in Edinburg. Gut. 1992;33:1011–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Slone S. Kumar A, Richter JE. Community approach to the diagnosis of achalasia: High resolution manometry is helping but needs to be earlier than later. DDW 2021.

  28. Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil. 2009;21(8):796–806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.

    Article  CAS  PubMed  Google Scholar 

  31. Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: chicago classification version 4.0((c)). Neurogastroenterol Motil. 2021;33(1):e14058.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chavez YH, Ciarleglio MM, Clarke JO, et al. Upper esophageal abnormalities. Frequent finding on high resolution esophageal manometry and associated with poorer treatment response in achalasia. J Clin Gastroenterol. 2015;49:17–23.

    Article  CAS  PubMed  Google Scholar 

  33. Yoneyama F, Miyacki M, Nimura Y. Manometric findings of the upper esophageal sphincter in esophageal achalasia. World J Surg. 1998;22:1043–6.

    Article  CAS  PubMed  Google Scholar 

  34. Richter JE. The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult. Clin Gastroenterol Hepatol. 2011;9(12):1010–1.

    Article  PubMed  Google Scholar 

  35. de Oliveira JM, Birgisson S, Doinoff C, et al. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol. 1997;169(2):473–9.

    Article  PubMed  Google Scholar 

  36. Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113(2):196–203.

    Article  PubMed  Google Scholar 

  37. Zaninotto G, Bennett C, Boeckxstaens G, et al. the 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31:1–29.

    Article  Google Scholar 

  38. Vaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50(6):765–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow for assessing long-term treatment response in patients with achalasia: Absolute cutoff versus percent change - A cross-sectional analytic study. Neurogastroenterol Motil 2020:e14005.

  40. Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328–35.

    Article  PubMed  Google Scholar 

  41. Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Carlson DA, Lin Z, Rogers MC, Lin CY, Kahrilas PJ, Pandolfino JE. Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study. Neurogastroenterol Motil. 2015;27(7):981–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ponds FA, Bredenoord AJ, Kessing BF, Smout AJ. Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation. Neurogastroenterol Motil 2017;29(1).

  45. Arora Z, Thota PN, Sanaka MR. Achalasia: current therapeutic options. Ther Adv Chronic Dis. 2017;8(6–7):101–8.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Wen ZH, Gardner E, Wang YP. Nitrates for achalasia. Cochrane database of systematic reviews. 2004; CD002299

  47. Prakash C, Freeland KE, Chan ME, Clause RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol. 1999;94:328–33.

    Article  CAS  PubMed  Google Scholar 

  48. Renske AB, Nijhuis O, Prius LT, et al. Factors associated with achalasia treatments outcomes: systematic review and meta-analysis. Clinical Gastroenterol Hepatol. 2021;18:1442–53.

    Google Scholar 

  49. Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical guidelines: diagnosis and management of Achalasia. Am J Gastroenterol. 2020;115(9):1393–411.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60(6):869–76.

    Article  PubMed  Google Scholar 

  51. Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol. 2008;2(3):435–45.

    Article  PubMed  Google Scholar 

  52. Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J. Treatment of achalasia with pneumatic dilatations. Gut. 1971;12(4):268–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc. 1997;45(5):349–53.

    Article  CAS  PubMed  Google Scholar 

  54. Ghoshal UC, Kumar S, Saraswat VA, Aggarwal R, Misra A, Choudhuri G. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004;99(12):2304–10.

    Article  CAS  PubMed  Google Scholar 

  55. Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8(1):30–5.

    Article  PubMed  Google Scholar 

  56. Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.

    Article  CAS  PubMed  Google Scholar 

  57. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013;144(4):718–725; quiz e713–714.

  58. Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–9.

    Article  PubMed  Google Scholar 

  59. Br O, Chang L, Pelligrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surgery. 2003;138:490–5.

    Article  Google Scholar 

  60. Richards WO, Torquari A, Holtzman MD, et al. Heller myotomy vs Heller myotomy and Dor fundoplication for achalasia: a prospective randomized double blind study. Ann Surg. 2004;240:405–12.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249:45–57.

    Article  PubMed  Google Scholar 

  62. Werner Y, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381:2219–29.

    Article  PubMed  Google Scholar 

  63. Li J, Lieb J, Gianos JM, et al. Reasons and prevalence of reoperations after esophagomyotomy for achalasia. Surg Laprosc Endo Percutan Tech. 2012;22:392–5.

    Google Scholar 

  64. Guo JP, Gilman PB, Thomas RM, et al. Barrett’s esophagus and achalasia. J Clin Gastroenterol. 2002;34:439–43.

    Article  PubMed  Google Scholar 

  65. Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.

    Article  CAS  PubMed  Google Scholar 

  66. Stavropoulos SN, Friedel D, Modayil R, Iqbal S, Grendell JH. Endoscopic approaches to treatment of achalasia. Therap Adv Gastroenterol. 2013;6(2):115–35.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology. 2017;153(5):1205–11.

    Article  PubMed  Google Scholar 

  68. Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112(8):1267–76.

    Article  PubMed  Google Scholar 

  69. Patel KS, Calixte R, Modayil RJ, Friedel D, Brathwaite CE, Stavropoulos SN. The light at the end of the tunnel: a single-operator learning curve analysis for per oral endoscopic myotomy. Gastrointest Endosc. 2015;81(5):1181–7.

    Article  PubMed  Google Scholar 

  70. Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol 2018;16(9):1420–1426 e1422.

  71. Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–44.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Andolfi C, Fisichella PM. Meta-analysis of clinical outcome after treatment for achalasia based on manometric subtypes. Br J Surg. 2019;106(4):332–41.

    Article  CAS  PubMed  Google Scholar 

  73. Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018;87(4):934–943 e918.

  74. Ichkhanian Y, Benias P, Khashab MA. Case of early Barrett cancer following peroral endoscopic myotomy. Gut. 2019;68(12):2107–10.

    Article  CAS  PubMed  Google Scholar 

  75. Ratuapli SK, Crowell MD, Dibuse JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.

    Article  CAS  PubMed  Google Scholar 

  76. Babari A, Szabo A, Shad S, et al. Chronic daily opioid exposure is associated with dysphagia, EGJ outflow obstruction and disordered perstalsis. Neurogastroenterol Motil. 2019;31:e13601.

    Google Scholar 

  77. Ortiz V, Garcia-Campo M, Saez-Gonzales E, et al. A concise review of opioid-induced esophageal dysfunction: Is this a new clinical entity? Dis Esophagus. 2018;31:1–6.

    Article  Google Scholar 

  78. Snyder DL, Crowell MD, Horsley-Silva J, et al. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464–9.

    Article  PubMed  Google Scholar 

  79. Richter JE. Tailoring therapy for achalasia. Gastroenterol and Hepatol. 2020;16:249–56.

    Google Scholar 

  80. Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: pancea, placebo or pathway to the future. Gastroenterol Hepatol. 2008;5:283–95.

    Google Scholar 

  81. Jacobs J, Richter JE. Opening the bird’s beak: tips and tricks for effective pneumatic dilation for achalasia. Am J Gastroenterol. 2016;111(2):157–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Invited review. Subject headings equally divided up among 3 authors who did literature search and wrote their sections. Senior author (JR) put the entire manuscript together.

Corresponding author

Correspondence to Joel E. Richter.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

The authors did not receive support from any organization for the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blonski, W., Slone, S. & Richter, J.E. Update on the Diagnosis and Treatment of Achalasia. Dysphagia 38, 596–608 (2023). https://doi.org/10.1007/s00455-022-10435-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00455-022-10435-3

Keywords

Navigation